Efficacy and safety of ruxolitinib plus extracorporeal photopheresis in acute and chronic graft versus host disease: A single center experience. (2021). Annals of Medical Research, 28(11), 2065-2070. http://www.annalsmedres.org/index.php/aomr/article/view/3977